Cargando…
Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review
INTRODUCTION: Patients with hematological malignancies (HMs), like chronic lymphocytic leukemia (CLL), multiple myeloma (MM), and non-Hodgkin lymphoma (NHL), have a high risk of secondary immunodeficiency (SID), SID-related infections, and mortality. Here, we report the results of a systematic liter...
Autores principales: | Jolles, Stephen, Giralt, Sergio, Kerre, Tessa, Lazarus, Hillard M., Mustafa, S. Shahzad, Ria, Roberto, Vinh, Donald C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941665/ https://www.ncbi.nlm.nih.gov/pubmed/36824125 http://dx.doi.org/10.3389/fonc.2023.1098326 |
Ejemplares similares
-
P1589: AGENTS CONTRIBUTING TO SECONDARY IMMUNODEFICIENCY DEVELOPMENT IN PATIENTS WITH MULTIPLE MYELOMA, CHRONIC LYMPHOCYTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW
por: Jolles, S., et al.
Publicado: (2022) -
Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia
por: Allegra, Alessandro, et al.
Publicado: (2021) -
Contemporary Management of Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
por: Kurtin, Sandra E., et al.
Publicado: (2018) -
Vitamin D levels in patients with non-Hodgkin lymphoma/diffuse large B-cell lymphoma, chronic lymphocytic leukemia and multiple myeloma
por: Graklanov, Vasko, et al.
Publicado: (2020) -
Hodgkin lymphoma transformation of chronic lymphocytic leukemia: cases report and discussion
por: Kaźmierczak, Maciej, et al.
Publicado: (2013)